Healthy Skepticism Library
Items published during the years 1990 to 1999
There are 2362 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.
Page 13 of 24 pages ‹ First < 11 12 13 14 15 > Last ›
HSL6533
Levy R, Smith M.
Rx marketing’s real value
Pharmaceutical Executive 1994 Oct66-72
HSL6534
Lexchin J.
Re: the promotion of Zovirax (acyclovir)
MaLAM International News 1994 Oct;
HSL6535
Peny JM.
ACE-inhibitors—an analysis of marketing strategy
Scrip Magazine 1994 Oct; (28):18-21
www.pjbpubs.co.uk/scrip/scrhome.html
HSL9208
Schwartz H.
Two sides to industry coins
Pharmaceutical Executive 1994 Oct; 14:28, 32
HSL9215
Emmerton L, Gow DJ, Benrimoj SI.
Dimensions of pharmacists' preferences for cough and cold products
International Journal of Pharmacy Practice 1994 Oct; 3:
HSL9233
Gatty B.
Feds widen probe of pharmaceutical industry marketing and promotional practices
Hospital Formulary 1994 Oct; 29:724, 723
HSL20268
Bucher HC, Weinbacher M, Gyr K
Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholestrol concentration
BMJ 1994 Sep 24; 309:(6957):761-4
http://www.ncbi.nlm.nih.gov/pubmed/7950558
HSL19830
Choo V
OTC drug advertisements
The Lancet 1994 Sep 17; 344:(8925):813
http://www.lancet.com/journals/lancet/article/PIIS0140-6736%2894%2992367-1/fulltext
HSL5910
Greenwald M.
Interacting with the pharmaceutical industry.
CMAJ 1994 Sep 15; 151:(6):731
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8087745
HSL6467
Stopps RG.
Interacting with the pharmaceutical industry.
CMAJ 1994 Sep 15; 151:(6):731-2
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8087746
HSL6038
Kassirer JP, Angell M.
The journal's policy on cost-effectiveness analyses.
N Engl J Med 1994 Sep 8; 331:(10):669-70
HSL6041
Little bigger, little better.
Lancet. 1994 Sep 3; 344:(8923):627-8
HSL6436
Myers CE.
Misrepresenting an ASHP practice standard for commercial purposes.
Am J Hosp Pharm 1994 Sep 1; 51:(17):2107-8
HSL1860
Mantyranta T, Hemminki E.
Medical students and drug promotion.
Acad Med 1994 Sep; 69:(9):736
HSL6521
MSD have promised to cease marketing Periactin as an appetite stimulant
MaLAM International News 1994 Sep; 12:(5):1-2
HSL6522
Pitkin RM.
Conflict of interest.
Obstet Gynecol 1994 Sep; 84:(3):458-9
HSL6523
Merck Sharp & Dohme associates Zocor with “Success•Acceptance•Confidence”
MaLAM Australian News 1994 Sep-Oct; 2:(3):1-4
HSL6524
Harper J.
For-profit entities and continuing education: a nursing perspective.
Nurs Outlook 1994 Sep-Oct; 42:(5):217-22
HSL9222
Judgement day
National Association of Retail Druggists Journal 1994 Sep; 116:18-20, 23-24
HSL9229
Davies R.
Implications for pharmacy in manufacturers' acquisitions
Australian Journal of Pharmacy 1994 Sep; 75:826
HSL9235
Chi J.
How the growing clamor for rebates will affect you
Hospital Pharmacist Report 1994 Sep; 8:28
HSL6152
Lexchin J.
Relations with the pharmaceutical industry.
CMAJ 1994 Aug 15; 151:(4):413-4
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8055397
HSL6463
Sterns EE.
Relations with the pharmaceutical industry.
CMAJ 1994 Aug 15; 151:(4):414-5
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8055398
HSL6453
Rubin PH.
Pharmaceutical promotion and physician requests to hospital formularies.
JAMA 1994 Aug 3; 272:(5):355
HSL9239
Cehelsky JE.
Bungyo in Japan.
Am J Hosp Pharm 1994 Aug 1; 51:(15):1965
HSL6519
Kaldeway H, Wieringa N, Herxheimer A, Vos R
A searching look at advertisements: a content analysis of magazine and newspaper advertisements for OTC medicines and health products in 11 countries
London: International Organisation of Consumers Unions 1994 Aug
HSL6520
Mansfield P.
Re: the promotion of Bactrim (co-trimoxazole)
Medical Lobby for Appropriate Marketing 1994 Aug;
HSL20391
Schwartz JS
Measuring quality: Where are we? Where Are We Going? And How Will We Know When We Get There?
Annals of the New York Academy of Sciences 1994 Aug; 729:150-158
http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.1994.tb12228.x/abstract
HSL20553
Dean M
Capping drug costs
The Lancet 1994 July 30; 344:321
http://www.sciencedirect.com/science/article/pii/S0140673694913471
HSL9216
Conlan MF.
New probe of pill profits
Drug Topics 1994 Jul 25; 138:50
HSL6449
Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC.
Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal.
JAMA 1994 Jul 13; 272:(2):108-13
HSL19879
Thompson M
GPs happy to receive drug company gifts
New Zealand Doctor News 1994 July 7
HSL19880
Baker S
Drug industry pledges greater self scrunity
New Zealand Doctor News 1994 July 74
HSL6153
Lexchin J, Holbrook A.
Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
CMAJ 1994 Jul 1; 151:(1):47-54
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8004560
HSL6442
Peay MY, Peay ER.
Innovation in high risk drug therapy.
Soc Sci Med 1994 Jul; 39:(1):39-52
HSL6514
Lexchin J.
Re: the promotion of Dialyl (phthalylsulfathiazole with nifuroxazide)
1994 Jul;
HSL6515
Mansfield P.
Re: the promotion of Prothiaden (dothiepin)
1994 Jul;
HSL6516
Prescription drugs: little is known about the effects of direct-to-consumer advertising
1994 Jul
HSL9223
Rankin K.
Generic drugs are primed for growth explosion
Drug Store News for the Pharmacist 1994 Jul; 4:15-16, 20, 27
HSL9237
Charupatanapong N, McCormick WC, Zatopek S.
Learning experience from community pharmacy owners
American Association of Colleges of Pharmacy Annual Meeting 1994 Jul; 95:
HSL6510
Green MS.
Authorship! Authorship!
JAMA 1994 Jun 22-29; 271:(24):1904
HSL6511
Kasper CK.
Authorship! Authorship!
JAMA 1994 Jun 22-29; 271:(24):1904
HSL6512
Rennie D, Flanagin A.
Authorship! Authorship! [reply]
JAMA 1994 Jun 22-29; 271:(24):1904
HSL19892
Prescrire on 'commercial' drug launches
SCRIP 1994 Jun 21; 1933:29
HSL5898
Cooper DA, Kaldor J.
Inadvertent placement of advertisements.
Med J Aust 1994 Jun 6; 160:(11):727
HSL6498
Kaur SR.
Safe, effective and affordable drugs for all
HAI News 1994 Jun; (77):1-2, 11-12
HSL6499
Lexchin J.
Re: the promotion of Baralgin (dipyrone/pitofenone/fenpiverinium)
1994 Jun;
HSL9227
Drug makers, distributors are reshaping pharmacy
Business and Health 1994 Jun; 12:18
HSL20556
Friestad M, Wright P
The Persuasion Knowledge Model: How People Cope with Persuasion Attempts
Journal of Consumer Research 1994 Jun; 21:(1):1-31
http://www.jstor.org/discover/10.2307/2489738?uid=3737536&uid=2129&uid=2&uid=70&uid=4&sid=21102165584431
HSL9303
Edgar TA, Lee DS, Cousins DD.
Experience with a national medication error reporting program.
Am J Hosp Pharm 1994 May 15; 51:(10):1335-8
HSL5342
Kleinman I, Brown P, Librach L.
Placebo pain medication. Ethical and practical considerations.
Arch Fam Med 1994 May 01; 3:(5):453-7
HSL9242
Drug price increases at retail level still outpace inflation, Senate aging committee report says
Am J Hosp Pharm 1994 May 1; 51:1139-1140
HSL1868
Slawson DC, Shaughnessy AF, Bennett JH.
Becoming a medical information master: feeling good about not knowing everything.
J Fam Pract 1994 May; 38:(5):505-13
HSL6473
Thomson AN, Craig BJ, Barham PM.
Attitudes of general practitioners in New Zealand to pharmaceutical representatives.
Anthrozoos 1994 May; 44:(382):220-3
HSL9228
Debrovner D.
Nothing to sneeze at
American Druggist 1994 May; 210:36-40
HSL20546
Chetley A
Bangladesh drug policy hanging in the balance
The Lancet 1994 Apr 16; 343:967
http://www.lancet.com/journals/lancet/article/PIIS0140-6736%2894%2990078-7/fulltext
HSL9245
Davies R.
Consultant pharmacy: update. Part 2
Aust J Pharm 1994 Apr 11; 75:320
HSL9298
Dhalla M.
Manufacturers and pharmacists struggle to agree in margins debate
Pharm J 1994 Apr 2; 252:477-478
HSL6490
PMAC public information program unprecedented success
PMAC News 1994 Apr; 10-11
www.canadapharma.org
HSL6491
Levy R.
The role and value of pharmaceutical marketing.
Arch Fam Med 1994 Apr; 3:(4):327-32
HSL6492
Wind Y.
Pharmaceutical advertising: A business school perspective
Archives of Family Medicine 1994 4; 3:321-323
HSL9226
Edlin M.
Prescription of change
Managed Healthcare 1994 Apr; 4:20-21, 24
HSL20509
McNamee D
Across the drug- information divide
The Lancet 1994 Mar 19; 343:725
http://www.lancet.com/journals/lancet/article/PIIS0140-6736%2894%2991595-4/fulltext
HSL5903
Erola JA.
We need dialogue and discussion, not a new Berlin Wall.
CMAJ 1994 Mar 15; 150:(6):955-6
HSL6026
Guyatt G.
Academic medicine and the pharmaceutical industry: a cautionary tale.
CMAJ 1994 Mar 15; 150:(6):951-3
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8131127
HSL9297
Rankin K.
Will community pharmacy be locked out of health reform?
Drug Store News for Pharm 1994 Mar 14; 4:13-14, 16, 19
HSL6489
Kleiner K.
A sackful of money helps the medicine go down
New Scientist 1994 Mar 12; 6-7
HSL2312
Chren MM, Landefeld CS.
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.
JAMA 1994 Mar 2; 271:(9):684-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
HSL6454
Scott DK, Ferner RE.
'The strategy of desire' and rational prescribing.
Br J Clin Pharmacol 1994 Mar; 37:(3):217-9
HSL6487
Reidenberg MM.
The Pinocchio factor.
Clin Pharmacol Ther 1994 Mar; 55:(3):247-8
HSL9300
Kale MV, Sharp WT, Cady PS, Adamcik BA.
FDA: can it keep up with the times ahead?
1994 Mar; 141:153
HSL9301
Mishra A, Rappaport HM.
Alteration of the Total Prescription Volume of a Product Class by a New Molecular Entity
APhA Annual Meeting 1994 Mar; 141:58
HSL9304
Veverka MJ.
User fee program: implementation
Pharm Eng 1994 Mar-Apr; 14:48-50
HSL6032
Healing E.
Conflicts of interest and the Journal's policies.
N Engl J Med 1994 Feb 17; 330:(7):503
HSL6486
Rennie D, Flanagin A.
Authorship! Authorship! Guests, ghosts, grafters, and the two-sided coin.
JAMA 1994 Feb 9; 271:(6):469-71
HSL6485
Skolnick AA.
Pro-free enterprise group challenges FDA's authority to regulate drug companies' speech.
JAMA 1994 Feb 2; 271:(5):332,
HSL6445
Poirier TI, Giannetti V, Giudici RA.
Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
Am J Hosp Pharm 1994 Feb 1; 51:(3):378-81
HSL6469
Swanson RW, Hall WG, Jennett PA.
Pharmaceutical representatives--educators or product marketers?
Acad Med 1994 Feb; 69:(2):128-9
HSL6476
van Trigt AM, de Jong-van den Berg LT, Haaijer-Ruskamp FM, Willems J, Tromp TF.
Journalists and their sources of ideas and information on medicines.
Soc Sci Med 1994 Feb; 38:(4):637-43
HSL9241
Laskoski G.
Dynamic duos
Am Drug 1994 Feb; 209:20-22, 24
HSL15819
Markman M.
Pharmaceutical advertising and the cost of medical care
Journal of Cancer Research and Clinical Oncology 1994 Feb; 120:(4):
http://www.springerlink.com/content/m45r75153l76x0r2/
HSL6438
O'Sullivan DP.
Bromocriptine and drug information.
Lancet 1994 Jan 29; 343:(8892):297
HSL6484
“Knowledge is the best medicine” PMAC launches health promotion campaign
PMAC Bulletin 1994 Jan 28; (1/94):3-4
www.canadapharma.com
HSL6450
Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL, Chalmers TC.
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.
Arch Intern Med 1994 Jan 24; 154:(2):157-63
HSL6154
Maher EA.
An analysis of finder's fees in clinical research.
CMAJ 1994 Jan 15; 150:(2):252-6
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8287347
HSL6479
Williams JR.
CMA issues revised guidelines on physicians' relationship with pharmaceutical industry.
CMAJ 1994 Jan 15; 150:(2):263,
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8287352
HSL6459
Smith R.
Conflict of interest and the BMJ.
BMJ 1994 Jan 1; 308:(6920):4-5
http://www.bmj.com/cgi/content/full/308/6920/4
HSL6150
Lexchin J.
Appetite stimulant claim deleted from label.
Can Fam Physician 1994 Jan; 40:20,:
HSL6441
Patel JC.
The gifts and trinkets to doctors: current practice in India and global trends in pharmaceutical industry.
Indian J Med Sci 1994 Jan; 48:(1):20-30
HSL673
Kessler DA, Rose JL, Temple RJ, Schapiro R, Griffin JP.
Drug promotion.
N Engl J Med 1994; 331:(10):1350
HSL2135
Berings D, Blondeel L, Habraken H.
The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice.
Eur J Clin Pharmacol 1994; 46:(6):501-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7995315&dopt=Abstract
HSL2316
Engle , R .
The Impact of a Single-Advertiser Publication on Physicians’ Perceptions and Expected Prescribing Behaviour.
Journal of Pharmaceutical Marketing and Management 1994; 8:(1):37-54
HSL5711
CIOMS/WHO meeting on Ethical Criteria for Medicinal Drug Promotion
Essential Drugs Monitor 1994
HSL5712
Drug discussions at the 47th World Health Assembly
Essential Drugs Monitor 199414-15
HSL5713
Japanese drug manufacturers adopt new marketing code
Essential Drugs Monitor 199419
HSL5714
Knowledge is the best medicine. Campaign update January 17 to June 12, 1994
1994
HSL5715
OTA study reports on drug labelling in developing countries
Essential Drugs Monitor 199419
HSL5716
RMI code of practice
New Zealand Medical Journal 1994; 107:383
HSL5717
Thai seminar on drug promotion
Essential Drugs Monitor 19945
HSL5718
Ahmad SR.
Lilly’s misleading promotion
Lancet 1994; 344:464-465
Page 13 of 24 pages ‹ First < 11 12 13 14 15 > Last ›
